Clinical Trial Update: Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase II pharmacokinetics trial evaluating Humalog and Humulin-R with and without rHuPH20 in Type 1 Diabetes Mellitus completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)
• Humulin R
• rHuPH20 (recombinant human hyaluronidase PH20)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-09-05